New hope for hard-to-treat brain cancer: combo therapy enters trial
NCT ID NCT06931652
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug called epcoritamab, given with two other drugs (lenalidomide and rituximab), for people whose primary CNS lymphoma has returned or stopped responding to treatment. The goal is to see if this combination can shrink or control the cancer. About 60 adults will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY CNS LYMPHOMA (PCNSL) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHR DE MARSEILLE - CHU TIMONE - Service de Neuro-Oncologie
ACTIVE_NOT_RECRUITINGMarseille, France
-
CHRU DE NANCY - HOPITAL CENTRAL - Service de Neurologie
ACTIVE_NOT_RECRUITINGNancy, France
-
CHU BRETONNEAU - Service Cancérologie - Hématologie et Thérapie Cellulaire
RECRUITINGTours, France
Contact Email: •••••@•••••
-
CHU DE LILLE - HOPITAL CLAUDE HURIEZ - Service des Maladies du Sang
RECRUITINGLille, France
Contact
-
CHU ESTAING - Service Thérapie Cellulaire et Hématologie Clinique
RECRUITINGClermont-Ferrand, France
Contact
-
CHU LYON-SUD - Hématologie Clinique
RECRUITINGPierre-Bénite, France
Contact
-
CHU PONTCHAILLOU - Hématologie Clinique
ACTIVE_NOT_RECRUITINGRennes, France
-
GHU PITIE-SALPETRIERE - CHARLES FOIX - Service Neurologie
RECRUITINGParis, France
Contact
-
HOPITAL DE LA PITIE SALPETRIERE - Service Hématologie Clinique
ACTIVE_NOT_RECRUITINGParis, France
-
INSTITUT BERGONIE - Service d'Oncologie Médicale
RECRUITINGBordeaux, France
Contact
-
INSTITUT CURIE - SITE SAINT-CLOUD - Service Hématologie
RECRUITINGSaint-Cloud, France
Contact
-
INSTITUT D'HEMATOLOGIE DE BASSE NORMANDIE - Service Hématologie
RECRUITINGCaen, France
Contact
-
IUCT ONCOPOLE - Service Hématologie
RECRUITINGToulouse, France
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New drug cocktail targets Hard-to-Treat brain cancer
- Could less chemo be better? new trial aims to reduce treatment burden for brain lymphoma
- New Gene-Modified immune cells take on tough lymphoma
- Experimental CAR-T therapy targets Hard-to-Treat brain cancer
- Immunotherapy duo takes on tough lymphomas
- New cocktail aims to tame rare brain cancer